Beijing Leadman Biochemistry Co.,Ltd. Announces Earnings Results for the Half Year Ended June 30, 2021
August 12, 2021 at 07:08 am EDT
Share
Beijing Leadman Biochemistry Co.,Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 245.516 million compared to CNY 176.133 million a year ago. Operating income was CNY 30.755 million compared to CNY 12.136 million a year ago. Net income was CNY 13.564 million compared to net loss of CNY 5.957 million a year ago. Basic earnings per share from continuing operations was CNY 0.0325 compared to basic loss per share from continuing operations of CNY 0.0143 a year ago.
Beijing Leadman Biochemistry Co., Ltd is a China-based company principally engaged in the research, development, production and sales of in-vitro diagnostic reagents. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The Company also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The Company mainly operates businesses in domestic market.
BEIJING LEADMAN BIOCHEMISTRY CO.,LTD. 
